Limited metastatic pancreatic cancer research hub

Safety and efficacy of IMM-101 combined with stereotactic radiotherapy in patients with limited metastatic pancreatic cancer (MEPANC-1)

This study looks at a new treatment called IMM-101 combined with special radiotherapy for pancreatic cancer that has spread a little. It checks how safe the treatment is and how well it works to control the cancer.